Market Overview

Adam Feuerstein, Responding To A Tweet That Citron Will Have More Abbvie Reports Out Soon, Tweets 'This promotional front-running nonsense erodes credibility.' (2/2)

Share:

This headline-only article is meant to show you why a stock is moving, the most difficult aspect of stock trading. Every day we publish hundreds of headlines on any catalyst that could move the stocks you care about on Benzinga Pro, our flagship platform for fast, actionable information that promotes faster, smarter trading.

Benzinga Pro has an intuitively designed workspace that delivers powerful market insight, and is the solution of choice for thousands of professional and retail traders across the world.

Stop Googling for information and check out Benzinga Pro. You will never again be left in the dark on when a stock moves. You’ll have what you need to act in real-time — before the crowd.

Start your FREE 14-day trial of Benzinga Pro today.

Posted-In: Citron ResearchNews Short Sellers Media

 

Related Articles (ABBV)

Sellas Life Sciences' Cancer Vaccine Candidate Wins Fast Track Designation In Multiple Myeloma

After Skechers Issues Weak Guidance, Wells Fargo Predicts First Annual EPS Decline Since 2011